Discovery of Potent Tetrazole Free Fatty Acid Receptor 2 Antagonists

被引：2
|
作者：
Valentini, Alice [3 ]
Schultz-Knudsen, Katrine [3 ]
Hansen, Anders Hojgaard [2 ]
Tsakoumagkou, Argyro [3 ]
Jenkins, Laura [1 ]
Christensen, Henriette B. [2 ]
Manandhar, Asmita [3 ]
Milligan, Graeme [1 ]
Ulven, Trond [2 ,3 ]
Ulven, Elisabeth Rexen [3 ]
机构：
[1] Univ Glasgow, Coll Med Vet & Life Sci, Ctr Translat Pharmacol, Sch Mol Biosci, Glasgow G12 8QQ, Scotland
[2] Univ Southern Denmark, Dept Phys Chem & Pharm, DK-5230 Odense M, Denmark
[3] Univ Copenhagen, Dept Drug Design & Pharmacol, DK-2100 Copenhagen, Denmark
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2023年 / 66卷 / 09期
基金：
英国生物技术与生命科学研究理事会;
关键词：
FFA2; ANTAGONIST; FUNCTIONAL-CHARACTERIZATION; GLUCOSE-TOLERANCE; GUT MICROBIOTA; DIETARY FIBER; AGONIST; GPR43; IDENTIFICATION; GLPG0974; SAFETY;
D O I：
10.1021/acs.jmedchem.2c01935
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The free fatty acid receptor 2 (FFA2), also known as GPR43, mediates effects of short-chain fatty acids and has attracted interest as a potential target for treatment of various metabolic and inflammatory diseases. Herein, we report the results from bioisosteric replacement of the carboxylic acid group of the established FFA2 antagonist CATPB and SAR investigations around these compounds, leading to the discovery of the first high potency FFA2 antagonists, with the preferred compound TUG 2304 (16l) featuring IC50 values of 3-4 nM in both cAMP and GTP gamma S assays, favorable physicochemical and pharmacokinetic properties, and the ability to completely inhibit propionate induced neutrophil migration and respiratory burst.
引用
收藏
页码：6105 / 6121
页数：17
相关论文
共 50 条
  • [41] THE DISCOVERY OF POTENT NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS - A NEW CLASS OF POTENT ANTIHYPERTENSIVES
    DUNCIA, JV
    CHIU, AT
    CARINI, DJ
    GREGORY, GB
    JOHNSON, AL
    PRICE, WA
    WELLS, GJ
    WONG, PC
    CALABRESE, JC
    TIMMERMANS, PBMWM
    JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (05) : 1312 - 1329
  • [42] Discovery of phenoxybutanoic acid derivatives as potent endothelin antagonists with antihypertensive activity
    Cai, Jin
    Liu, Ligang
    Hong, Kwon Ho
    Wang, Peng
    Li, Lushen
    Cao, Meng
    Sun, Chunlong
    Wu, Xiaoqing
    Zong, Xi
    Chen, Junqing
    Ji, Min
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (04) : 657 - 667
  • [43] Discovery of a Potent, Selective, and Orally Bioavailable Tool Compound for Probing the Role of Lysophosphatidic Acid Type 2 Receptor Antagonists in Fibrotic Disorders
    Armani, Elisabetta
    Rizzi, Andrea
    Iotti, Nicolo
    Saccani, Francesca
    Di Lascia, Maria Rosaria
    Tigli, Laura
    Pappani, Alice
    Marchini, Gessica
    Murgo, Annalisa
    Capelli, Anna Maria
    Delcanale, Maurizio
    Puccini, Paola
    Villetti, Gino
    Civelli, Maurizio
    Beato, Claudia
    Giuliani, Marta
    Mundi, Claudia
    Murarolli, Francesca
    Pagano, Mafalda
    Raveglia, Luca F.
    Remelli, Rosaria
    Amari, Gabriele
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (08) : 5622 - 5656
  • [44] Free fatty acid receptors and drug discovery
    Hirasawa, Akira
    Hara, Takafumi
    Katsuma, Susumu
    Adachi, Tetsuya
    Tsujimoto, Gozoh
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2008, 31 (10) : 1847 - 1851
  • [45] Improving metabolic stability with deuterium: The discovery of HWL-066, a potent and long-acting free fatty acid receptor 1 agonists
    Liu, Chunxia
    Li, Zheng
    Shi, Wei
    Li, Huilan
    Wang, Nasi
    Dai, Yuxuan
    Liao, Chen
    Huang, Wenlong
    Qian, Hai
    CHEMICAL BIOLOGY & DRUG DESIGN, 2018, 92 (02) : 1547 - 1554
  • [46] ORGN 54-Discovery of potent, selective, and orally bioavailable antagonists of CC Chemokine Receptor 2
    Carter, Percy H.
    Brown, Gregory D.
    Nelson, David J.
    Cherney, Robert J.
    Duncia, John V.
    Santella, Joseph B., III
    Gardner, Daniel S.
    Cvijic, Mary Ellen
    Mandlekar, Sandhya
    Tebben, Andrew J.
    Zhao, Qihong
    Decicco, Carl P.
    Barrish, Joel C.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
  • [47] Discovery of potent and selective phenylalanine derived CCR3 receptor antagonists. Part 2
    Dhanak, D
    Christmann, LT
    Darcy, MG
    Keenan, RM
    Knight, SD
    Lee, J
    Ridgers, LH
    Sarau, HM
    Shah, DH
    White, JR
    Zhang, LL
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (11) : 1445 - 1450
  • [48] Discovery of potent, selective, orally active benzoxazepine-based Orexin-2 receptor antagonists
    Fujimoto, Tatsuhiko
    Kunitomo, Jun
    Tomata, Yoshihide
    Nishiyama, Keiji
    Nakashima, Masato
    Hirozane, Mariko
    Yoshikubo, Shin-ichi
    Hirai, Keisuke
    Marui, Shogo
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (21) : 6414 - 6416
  • [49] Discovery of potent and selective DP1 receptor antagonists in the azaindole series
    Leblanc, Yves
    Roy, Patrick
    Dufresne, Claude
    Lachance, Nicolas
    Wang, Zhaoyin
    O'Neill, Gary
    Greig, Gillian
    Denis, Danielle
    Mathieu, Marie-Claude
    Slipetz, Deborah
    Sawyer, Nicole
    Tsou, Nancy
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (08) : 2125 - 2128
  • [50] DISCOVERY OF NONPEPTIDE, POTENT CONFORMATIONALLY RESTRICTED ANGIOTENSIN-II RECEPTOR ANTAGONISTS
    HUANG, HC
    CHAMBERLAIN, TS
    OLINS, GM
    CORPUS, VM
    CHEN, ST
    MCMAHON, EG
    PALOMO, MA
    BLAINE, EH
    MANNING, RE
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (21) : 2591 - 2596
12345